Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Issue Archive

Table of Contents

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
INSIDE BLOOD COMMENTARY
INSIDE BLOOD COMMENTARY
INSIDE BLOOD COMMENTARY

PERSPECTIVES

Peter Dreger,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Johannes Schetelig,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Niels Andersen,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Paolo Corradini,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Michel van Gelder,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),John Gribben,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Eva Kimby,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Mauricette Michallet,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Carol Moreno,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Stephan Stilgenbauer,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT),Emili Montserrat,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT)

EVIDENCE-BASED FOCUSED REVIEW

HOW I TREAT

CLINICAL TRIALS AND OBSERVATIONS

Dieter Hoelzer,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Jan Walewski,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Hartmut Döhner,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Andreas Viardot,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Wolfgang Hiddemann,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Karsten Spiekermann,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Hubert Serve,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Ulrich Dührsen,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Andreas Hüttmann,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Eckhard Thiel,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Jolanta Dengler,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Michael Kneba,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Markus Schaich,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Ingo G. H. Schmidt-Wolf,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Joachim Beck,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Bernd Hertenstein,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Albrecht Reichle,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Katarzyna Domanska-Czyz,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Rainer Fietkau,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Heinz-August Horst,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Harald Rieder,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Stefan Schwartz,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Thomas Burmeister,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia,Nicola Gökbuget,for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia
Peter W. Collins,for the paradigm 2 Investigators,Guy Young,for the paradigm 2 Investigators,Karin Knobe,for the paradigm 2 Investigators,Faraizah Abdul Karim,for the paradigm 2 Investigators,Pantep Angchaisuksiri,for the paradigm 2 Investigators,Claus Banner,for the paradigm 2 Investigators,Türkiz Gürsel,for the paradigm 2 Investigators,Johnny Mahlangu,for the paradigm 2 Investigators,Tadashi Matsushita,for the paradigm 2 Investigators,Eveline P. Mauser-Bunschoten,for the paradigm 2 Investigators,Johannes Oldenburg,for the paradigm 2 Investigators,Christopher E. Walsh,for the paradigm 2 Investigators,Claude Negrier,for the paradigm 2 Investigators

HEMATOPOIESIS AND STEM CELLS

IMMUNOBIOLOGY

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

PLATELETS AND THROMBOPOIESIS

RED CELLS, IRON, AND ERYTHROPOIESIS

THROMBOSIS AND HEMOSTASIS

TRANSPLANTATION

Effie W. Petersdorf,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Theodore A. Gooley,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Mari Malkki,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Andrea P. Bacigalupo,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Anne Cesbron,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Ernette Du Toit,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Gerhard Ehninger,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Torstein Egeland,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Gottfried F. Fischer,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Thibaut Gervais,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Michael D. Haagenson,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Mary M. Horowitz,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Katharine Hsu,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Pavel Jindra,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Alejandro Madrigal,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Machteld Oudshoorn,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Olle Ringdén,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Marlis L. Schroeder,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Stephen R. Spellman,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Jean-Marie Tiercy,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Andrea Velardi,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Campbell S. Witt,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Colm O’Huigin,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Richard Apps,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation,Mary Carrington,for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation

CONTINUING MEDICAL EDUCATION (CME) QUESTIONS

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals